Steve M Taylor, MD

Associate Professor of Medicine
Assistant Research Professor of Global Health
Campus mail 303 Research Drive, Sands Building #321a, Durham, NC 27710
Phone (919) 684-5815
Email address steve.taylor@duke.edu

My lab website has a fuller description of my research activities: https://sites.duke.edu/taylorlab/.

I am principally interested in field and translational studies of falciparum malaria. These interests fall along several lines:

1) Epidemiology. Falciparum malaria is an immense problem whose contours are difficult to discern in hyperendemic regions like much of sub-Saharan Africa. I am involved in field applications of molecular genetic techniques to better define the burden of parasitemia in endemic areas and the partitioning and flux of parasite populations. We are working on techniques to generate and parse high-dimensional genomic data to better understand the structure of these parasite populations. Ultimately the goal of these investigations is to inform measures to control malaria and contain distinct parasite populations.

2) Pathogenesis. Severe malaria is a lethal disease; it is the cause of most of the 400,000 malaria deaths annually in African children. In these children, sickle-trait hemoglobin confers >90% protection from severe, life-threatening malaria. Several lines of evidence support the hypothesis that this dramatic protection results from the inability of the parasite to export parasite-derived proteins to the surface of the infected human red blood cell. We are investigating the molecular genetic correlates of this phenomenon in in vitro and ex vivo systems in order to identify mechanisms by which sickle-trait neutralizes the parasite. By leveraging this naturally-occurring model of malaria protection we hope to ultimately identify druggable targets for future antiparasitic or adjunctive therapies.

3) Diagnostics. In the field, clinical practice guidelines now recommend parasitologic diagnosis of malaria prior to treatment. Parasite detection can be confirmed by traditional microscopy or by rapid immunochromatographic tests, but each of these approaches is potentially undermined by limits of detection, operator error, and the monoplex nature of parasite testing in settings with complex pathogen epidemiology. With collaborators in Biomedical Engineering at the Pratt School of Engineering, we are developing PCR-free multiplex detection assays that utilize robust, rapid, and scalable nanoengineered platforms that target multiple bloodborne tropical pathogens in a single assay. The ultimate goal of this project is to enhance the clinical management of febrile illness in the tropics.

4) Prevention. In malaria-endemic Africa, high-risk groups that suffer disproportionate malaria morbidity clearly benefit from antimalarial chemoprevention; these groups include pregnant women across Africa and children under 5 in West Africa. African children with sickle-cell anemia also suffer significant malaria morbidity, but chemoprevention regimens that are recommended for them lack a compelling evidence base. With partners in Malawi and Kenya, we are testing new approaches to malaria chemoprevention in both pregnant women and in children with sickle-cell anemia. The goal of these projects is to enhance public health guidelines for the routine care of these high-risk groups and reduce the burden of malaria in African children.

The ultimate goals of these translational studies of falciparum malaria in children and pregnant women is to integrate epidemiologic, clinical, and molecular genetic models of disease in order to inform the rational design of medical and public health interventions to reduce the awful burden of malaria.

Education and Training

  • Gillings School of Global Public Health - Postdoctoral Fellow, Department Of Epidemiology, University of North Carolina at Chapel Hill, 2008 - 2012
  • Fellowship, Infectious Diseases & International Health, Duke University School of Medicine, 2007 - 2012
  • Internship/Residency, Medicine, Yale University School of Medicine, 2004 - 2007
  • M.D., Duke University School of Medicine, 2004
  • M.P.H., University of North Carolina at Chapel Hill, 2003
  • B.S., Duke University, 1998

Publications

Taylor, Steve M., and Feiko O. Ter Kuile. “Stillbirths: the hidden burden of malaria in pregnancy.” Lancet Glob Health 5, no. 11 (November 2017): e1052–53. https://doi.org/10.1016/S2214-109X(17)30378-9.

PMID
28967611
Full Text

Patel, Jaymin C., Nicholas J. Hathaway, Christian M. Parobek, Kyaw L. Thwai, Mwayiwawo Madanitsa, Carole Khairallah, Linda Kalilani-Phiri, et al. “Increased risk of low birth weight in women with placental malaria associated with P. falciparum VAR2CSA clade.” Sci Rep 7, no. 1 (August 11, 2017): 7768. https://doi.org/10.1038/s41598-017-04737-y.

PMID
28801627
Full Text

Taylor, Steve M., Mwayiwawo Madanitsa, Kyaw-Lay Thwai, Carole Khairallah, Linda Kalilani-Phiri, Anna M. van Eijk, Victor Mwapasa, Feiko O. Ter Kuile, and Steven R. Meshnick. “Minimal Impact by Antenatal Subpatent Plasmodium falciparum Infections on Delivery Outcomes in Malawian Women: A Cohort Study.” The Journal of Infectious Diseases 216, no. 3 (August 2017): 296–304. https://doi.org/10.1093/infdis/jix304.

PMID
28658935
Full Text

Ter Kuile, Feiko O., and Steve M. Taylor. “Gilding the Lily? Enhancing Antenatal Malaria Prevention in HIV-Infected Women.” J Infect Dis 216, no. 1 (July 1, 2017): 4–6. https://doi.org/10.1093/infdis/jix111.

PMID
28329047
Full Text

Levitt, Brandt, Andrew Obala, Scott Langdon, David Corcoran, Wendy Prudhomme O’Meara, and Steve M. Taylor. “Overlap Extension Barcoding for the Next Generation Sequencing and Genotyping of Plasmodium falciparum in Individual Patients in Western Kenya.” Sci Rep 7 (January 24, 2017): 41108. https://doi.org/10.1038/srep41108.

PMID
28117350
Full Text

Nkhoma, Minyanga, Per Ashorn, Ulla Ashorn, Kathryn G. Dewey, Austrida Gondwe, John Mbotwa, Stephen Rogerson, Steve M. Taylor, and Kenneth Maleta. “Providing lipid-based nutrient supplement during pregnancy does not reduce the risk of maternal P falciparum parasitaemia and reproductive tract infections: a randomised controlled trial.” Bmc Pregnancy and Childbirth 17, no. 1 (January 17, 2017): 35. https://doi.org/10.1186/s12884-016-1215-2.

PMID
28095801
Full Text

Ngo, H. T., N. Gandra, A. M. Fales, S. M. Taylor, and T. Vo-Dinha. “DNA detection and single nucleotide mutation identification using SERS for molecular diagnostics and global health.” In Progress in Biomedical Optics and Imaging  Proceedings of Spie, Vol. 10054, 2017. https://doi.org/10.1117/12.2268779.

Full Text

Abel, Lucy, Rebeccah Nanjala Wafula, Daniel Evans, Steve M. Taylor, Wendy Prudhomme O’Meara, and Andrew A. Obala. “IMPLICATIONS OF REDUCED SUSCEPTIBILITY TO INSECTICIDES IN MALARIA VECTORS IN AN AREA WITH HIGH ITN COVERAGE.” In American Journal of Tropical Medicine and Hygiene, 97:456–456. AMER SOC TROP MED & HYGIENE, 2017.

Scholars@Duke

Kasili, P. M., and T. Vo-Dinh. “Monitoring apoptosis and anticancer drug activity in single cells using nanosensors.” In Nanotechnology in Biology and Medicine: Methods, Devices, and Applications, Second Edition, 423–38, 2017. https://doi.org/10.4324/9781315374581.

Full Text

Liu, Yunhao, Victor Mwapasa, Carole Khairallah, Kyaw L. Thwai, Linda Kalilani-Phiri, Feiko O. Ter Kuile, Steven R. Meshnick, and Steve M. Taylor. “Rapid Diagnostic Test Performance Assessed Using Latent Class Analysis for the Diagnosis of Plasmodium falciparum Placental Malaria.” Am J Trop Med Hyg 95, no. 4 (October 5, 2016): 835–39. https://doi.org/10.4269/ajtmh.16-0356.

PMID
27527628
Full Text

Pages